Baidu
map

Nat Genet:重磅!鉴别出调节人类机体肌肉量的关键基因

2017-01-10 佚名 生物谷

图片来源:medicalxpress.com 近日,一项刊登在国际杂志Nature Genetics上的研究报告中,来自阿伯丁大学的研究人员通过研究鉴别出了一种关键基因,该基因在确定人类机体肌肉质量上扮演着重要作用,机体的肌肉质量和一系列健康因子直接相关,其中就包括人类的寿命。 此前研究中,研究人员通过对老年人进行研究发现了机体肌肉量和预期寿命之间的关联。肌肉是机体中一种必不可少的关键组织

图片来源:medicalxpress.com

近日,一项刊登在国际杂志Nature Genetics上的研究报告中,来自阿伯丁大学的研究人员通过研究鉴别出了一种关键基因,该基因在确定人类机体肌肉质量上扮演着重要作用,机体的肌肉质量和一系列健康因子直接相关,其中就包括人类的寿命。

此前研究中,研究人员通过对老年人进行研究发现了机体肌肉量和预期寿命之间的关联。肌肉是机体中一种必不可少的关键组织,其能够发挥多种机体功能,比如让我们机体移动或者让我们自由呼吸。然而机体中骨骼肌肌肉量的水平却因人而异,存在着明显差异。

如果个体进行力量锻炼的话,其机体中骨骼肌量(skeletal muscle mass)的水平就会增加,但遗传因素在确定机体肌肉量的水平上同样扮演着相同重要的角色;如今研究人员通过研究鉴别出了影响小鼠机体肌肉量的关键基因,此外研究者此前通过研究还发现该基因和癌症的扩散存在直接关联,这对于后期科学家们开发新型疗法来靶向作用该基因就提供了新的思路和希望。

研究人员希望未来能够开发出新型药物来帮助他们理解该基因对肌肉组织的影响,如果有多重药物能够靶向作用相同的基因,那么研究者或许就能够找到对人类肌肉副作用娇小的药物。最后研究者表示,本文研究中所发现的新型基因在调节机体肌肉量上扮演着关键角色,同时未来他们有望开发出靶向作用该基因的新型药物来为治疗人类一系列疾病提供思路和希望。

原始出处:

Nicod J, Davies RW, Cai N, Hassett C, Goodstadt L, Cosgrove C, Yee BK, Lionikaite V, McIntyre RE, Remme CA, Lodder EM, Gregory JS, Hough T, Joynson R, Phelps H, Nell B, Rowe C, Wood J, Walling A, Bopp N, Bhomra A, Hernandez-Pliego P, Callebert J, Aspden RM, Talbot NP, Robbins PA, Harrison M, Fray M, Launay JM, Pinto YM, Blizard DA, Bezzina CR, Adams DJ, Franken P, Weaver T, Wells S, Brown SD, Potter PK, Klenerman P, Lionikas A, Mott R, Flint J.Genome-wide association of multiple complex traits in outbred mice by ultra-low-coveragesequencing.Nat Genet. 2016 Aug;48(8):912-8. doi: 10.1038/ng.3595.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1686048, encodeId=d666168604848, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sun Jul 23 09:38:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986859, encodeId=882f19868595d, content=<a href='/topic/show?id=d92e301e1a2' target=_blank style='color:#2F92EE;'>#关键基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30171, encryptionId=d92e301e1a2, topicName=关键基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Wed Apr 05 20:38:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881603, encodeId=16e018816033d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 13 21:38:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733813, encodeId=c0a51e33813bd, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue Oct 03 16:38:00 CST 2017, time=2017-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048758, encodeId=4bd32048e58e7, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Mon Dec 18 11:38:00 CST 2017, time=2017-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549007, encodeId=b29c154900ed5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Thu Jan 12 01:38:00 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1686048, encodeId=d666168604848, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sun Jul 23 09:38:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986859, encodeId=882f19868595d, content=<a href='/topic/show?id=d92e301e1a2' target=_blank style='color:#2F92EE;'>#关键基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30171, encryptionId=d92e301e1a2, topicName=关键基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Wed Apr 05 20:38:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881603, encodeId=16e018816033d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 13 21:38:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733813, encodeId=c0a51e33813bd, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue Oct 03 16:38:00 CST 2017, time=2017-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048758, encodeId=4bd32048e58e7, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Mon Dec 18 11:38:00 CST 2017, time=2017-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549007, encodeId=b29c154900ed5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Thu Jan 12 01:38:00 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1686048, encodeId=d666168604848, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sun Jul 23 09:38:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986859, encodeId=882f19868595d, content=<a href='/topic/show?id=d92e301e1a2' target=_blank style='color:#2F92EE;'>#关键基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30171, encryptionId=d92e301e1a2, topicName=关键基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Wed Apr 05 20:38:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881603, encodeId=16e018816033d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 13 21:38:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733813, encodeId=c0a51e33813bd, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue Oct 03 16:38:00 CST 2017, time=2017-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048758, encodeId=4bd32048e58e7, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Mon Dec 18 11:38:00 CST 2017, time=2017-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549007, encodeId=b29c154900ed5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Thu Jan 12 01:38:00 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-06-13 liye789132251
  4. [GetPortalCommentsPageByObjectIdResponse(id=1686048, encodeId=d666168604848, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sun Jul 23 09:38:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986859, encodeId=882f19868595d, content=<a href='/topic/show?id=d92e301e1a2' target=_blank style='color:#2F92EE;'>#关键基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30171, encryptionId=d92e301e1a2, topicName=关键基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Wed Apr 05 20:38:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881603, encodeId=16e018816033d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 13 21:38:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733813, encodeId=c0a51e33813bd, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue Oct 03 16:38:00 CST 2017, time=2017-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048758, encodeId=4bd32048e58e7, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Mon Dec 18 11:38:00 CST 2017, time=2017-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549007, encodeId=b29c154900ed5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Thu Jan 12 01:38:00 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-10-03 canlab
  5. [GetPortalCommentsPageByObjectIdResponse(id=1686048, encodeId=d666168604848, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sun Jul 23 09:38:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986859, encodeId=882f19868595d, content=<a href='/topic/show?id=d92e301e1a2' target=_blank style='color:#2F92EE;'>#关键基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30171, encryptionId=d92e301e1a2, topicName=关键基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Wed Apr 05 20:38:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881603, encodeId=16e018816033d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 13 21:38:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733813, encodeId=c0a51e33813bd, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue Oct 03 16:38:00 CST 2017, time=2017-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048758, encodeId=4bd32048e58e7, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Mon Dec 18 11:38:00 CST 2017, time=2017-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549007, encodeId=b29c154900ed5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Thu Jan 12 01:38:00 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-12-18 cy0324
  6. [GetPortalCommentsPageByObjectIdResponse(id=1686048, encodeId=d666168604848, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Sun Jul 23 09:38:00 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1986859, encodeId=882f19868595d, content=<a href='/topic/show?id=d92e301e1a2' target=_blank style='color:#2F92EE;'>#关键基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30171, encryptionId=d92e301e1a2, topicName=关键基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Wed Apr 05 20:38:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881603, encodeId=16e018816033d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jun 13 21:38:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733813, encodeId=c0a51e33813bd, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Tue Oct 03 16:38:00 CST 2017, time=2017-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048758, encodeId=4bd32048e58e7, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Mon Dec 18 11:38:00 CST 2017, time=2017-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549007, encodeId=b29c154900ed5, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Thu Jan 12 01:38:00 CST 2017, time=2017-01-12, status=1, ipAttribution=)]
    2017-01-12 xxxx1054

相关资讯

不是基因的错,越长越丑,可能是呼吸的方式阻碍你的美!

读这篇文章之前,先回答我两个问题。你现在专心致志看手机的这个时刻,嘴是微张着还是闭着?你在放松的时候,舌头放在哪里?如果你的答案不是“闭着”和“紧贴在我的上颚”,那你可能会想继续看下去。我们身边是否有这么几个人,他们的表情总像这样:告诉我,凭直觉,你觉得下图的男生,眼神中散发着智慧的光芒吗?他们闭上嘴拍照,你就答应跟他约会了?英国有一对同胞姐妹,七岁的妹妹Kelly(左)和八岁半的Samantha

eLife:sunitinib或可改善面肩肱型营养不良症患者的肌肉强度

近日,来自伦敦大学国王学院的牙科学院的研究人员发现,癌症药物sunitinib或可改善面肩肱型营养不良症(FSHD)患者的肌肉无力的情况,其研究结果已发表于eLife。研究中,研究人员发现RTK的一种类型——转染(RET)中重排——在肌肉干细胞或成肌细胞中的表达上调,RTK可表达DUX4 蛋白。该蛋白是由DUX4基因编码,位于FSHD患者的D4Z4区。FSHD患者中,D4Z4区域低甲基化,意味着需

J Proteome Res:在山里待上两周,你的血液就会发生改变

导语:经过一个晚上,人类的身体就会开始适应高海拔环境,而且这种适应能力所带来的生物学改变能够持续数月——也就是说,即使这个人后来返回了低海拔的环境,这种改变也会维持一段时间。最近,为了观察低氧环境中的多重变化如何影响红细胞的保有氧气的能力,科学家们有史以来第一次比较了登山者的血液——他们发现在几小时内登山者的血液就会发生改变。该研究反驳了一个持续了半个世纪的假说,该假说表明,与平均海拔地区的人相比

JNCI:弥漫性大B细胞淋巴瘤幸存者的身体成分变化研究

身体成分变化与长期的健康结果息息相关。我们对弥漫性大B细胞淋巴瘤(DLBCL)幸存者进行了研究,评估这些辛存者身体成分的纵向变化情况,识别与肌肉减少和内脏肥胖相关的临床因素。 这项回顾性队列研究纳入了使用环磷酰胺、阿霉素、长春新碱、强的松、伴或不伴利妥昔单抗治疗的DLBCL幸存者,所有患者来自美国的退伍军人。通过CT评估患者的肌肉、皮下脂肪和内脏脂肪面积。采用重复测量方差和logistic回

全新膝盖使用说明书,不收藏太亏啦!

简单来说,就是他们没有按照使用说明书来使用膝盖,机器的说明书在出厂的时候就会随机器放到包装里,人体的使用说明书自然和机器不一样,这个说明书需要我们自己去了解,去掌握~了解了膝盖的使用说明,膝盖就可以更安全、平稳地度过这70年,之后也同样可以按照“说明书”的建议来保养。膝盖使用说明书第一条男女膝盖寿命不一样我们自己感觉不到,但是世界卫生组织(WHO)统计的大数据表明:骨性关节炎在女性患病率中占第四位

医生支招:假期聚会,怎样喝酒才健康?

医生们掐指一算,这是国庆长假要到来的节奏。根据往年的经验,节日期间醉酒人数肯定还会持续增加。这也是可以理解,过节么,图的就是一个气氛。亲朋好友相聚一堂,桌上觥筹交错,推杯换盏,兴致一起,忘乎所以,稍不留神,烂醉如泥。饮酒在中国是一种礼仪,完全的杜绝饮酒还为时尚早,因此如何才能最大限度的减少酒精对健康的伤害,且听听医生怎么说。酒精对人体的伤害急诊科副主任张蓉认为,酒精对人体的损害,最重要的是中枢神经

Baidu
map
Baidu
map
Baidu
map